TissGeneSummary for GNAT1 |
Gene summary |
Basic gene information | Gene symbol | GNAT1 |
Gene name | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 | |
Synonyms | CSNBAD3|GBT1|GNATR | |
Cytomap | UCSC genome browser: 3p21 | |
Type of gene | protein-coding | |
RefGenes | NM_000172.3, NM_144499.2, | |
Description | guanine nucleotide-binding protein G(T), alpha-1 subunitguanine nucleotide-binding protein G(t) subunit alpha-1rod-type transducin alpha subunittransducin alpha-1 chaintransducin, rod-specific | |
Modification date | 20141207 | |
dbXrefs | MIM : 139330 | |
HGNC : HGNC | ||
HPRD : 08850 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GNAT1 | |
BioGPS: 2779 | ||
Pathway | NCI Pathway Interaction Database: GNAT1 | |
KEGG: GNAT1 | ||
REACTOME: GNAT1 | ||
Pathway Commons: GNAT1 | ||
Context | iHOP: GNAT1 | |
ligand binding site mutation search in PubMed: GNAT1 | ||
UCL Cancer Institute: GNAT1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | TestisEye | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCTUVM | |
Reference showing the relevant tissue of GNAT1 | ||
Description by TissGene annotations | Cancer gene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for GNAT1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for GNAT1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for GNAT1 |
TissGeneSNV for GNAT1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R172H | COAD | 1 |
p.R28* | SKCM | 1 |
p.W127* | LIHC | 1 |
p.S120L | STAD | 1 |
p.S94Y | UCEC | 1 |
p.E64Q | HNSC | 1 |
p.F187C | LUSC | 1 |
p.D285N | SKCM | 1 |
p.A134V | LGG | 1 |
p.K25N | SKCM | 1 |
p.I208V | LIHC | 1 |
p.R101W | UCEC | 1 |
p.E314K | SKCM | 1 |
p.A139T | STAD | 1 |
p.R138L | LUAD | 1 |
p.R172H | STAD | 1 |
p.I249V | LUSC | 1 |
p.L190F | BLCA | 1 |
p.T183M | CESC | 1 |
p.Q133K | MESO | 1 |
p.R174Q | CESC | 1 |
p.R101Q | UCEC | 1 |
p.A7V | COAD | 1 |
p.E21K | SKCM | 1 |
p.R96C | COAD | 1 |
p.V170M | COAD | 1 |
p.G92E | HNSC | 1 |
p.I217V | KIRC | 1 |
p.T183M | PAAD | 1 |
p.E14K | BLCA | 1 |
p.K205N | BLCA | 1 |
p.Q75R | LUAD | 1 |
p.A225T | STAD | 1 |
p.V170L | TGCT | 1 |
Top |
TissGeneCNV for GNAT1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for GNAT1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for GNAT1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for GNAT1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for GNAT1 |
TissGeneDrug for GNAT1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for GNAT1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0028077 | Night Blindness | 2 | BeFree,GAD |
umls:C0035309 | Retinal Diseases | 2 | GAD |
umls:C0339535 | Night blindness, congenital stationary | 2 | BeFree,ORPHANET |
umls:C1864870 | Night Blindness, Congenital Stationary, Autosomal Dominant 3 | 2 | CLINVAR,CTD_human,UNIPROT |
umls:C0011853 | Diabetes Mellitus, Experimental | 1 | RGD |